Diadema Partners Lp Top Holdings and 13F Report (2026)

About Diadema Partners Lp

Investment Activity

Diadema Partners Lp has $587.74 million in total holdings as of March 31, 2026.
Diadema Partners Lp owns shares of 111 different stocks, but just 28 companies or ETFs make up 80% of its holdings.
Approximately 50.94% of the portfolio was purchased this quarter.
About 50.27% of the portfolio was sold this quarter.
This quarter, Diadema Partners Lp has purchased 119 new stocks and bought additional shares in 39 stocks.
Diadema Partners Lp sold shares of 27 stocks and completely divested from 52 stocks this quarter.

Largest Holdings

United Therapeutics: $51,887,529
Vertex Pharmaceuticals: $43,287,588
Viking Therapeutics: $38,539,758
Capricor Therapeutics: $31,359,150
ABIVAX SA: $30,487,262

Largest New Holdings this Quarter

10806XAJ1 - BRIDGEBIO PHARMA INC: $18,565,000 Holding
23282W605 - Cytokinetics: $16,477,500 Holding
58933Y105 - Merck & Co., Inc.: $12,029,000 Holding
60770K107 - Moderna: $8,097,520 Holding
00287Y109 - AbbVie: $5,232,374 Holding

Largest Purchases this Quarter

United Therapeutics: 77,503 shares (about $45.96M)
Liquidia: 690,219 shares (about $26.05M)
ABIVAX SA: 200,300 shares (about $22.13M)
BRIDGEBIO PHARMA INC: 250,000 shares (about $18.57M)
Cytokinetics: 250,000 shares (about $16.48M)

Largest Sales this Quarter

BridgeBio Pharma: 324,289 shares (about $24.08M)
Johnson & Johnson: 62,673 shares (about $15.32M)
Terns Pharmaceuticals: 228,828 shares (about $12.06M)
Jazz Pharmaceuticals: 50,545 shares (about $9.56M)
Viking Therapeutics: 158,068 shares (about $5.14M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
UTHR United Therapeutics	$51,887,529	$45,957,729 â–²	775.0%	87,503	8.8%	Medical
VRTX Vertex Pharmaceuticals	$43,287,588	$607,294 â–¼	-1.4%	96,940	7.4%	Medical
VKTX Viking Therapeutics	$38,539,758	$5,143,533 â–¼	-11.8%	1,184,381	6.6%	Medical
CAPR Capricor Therapeutics	$31,359,150	$10,979,750 â–²	53.9%	1,031,551	5.3%	Medical
ABIVAX SA	$30,487,262	$22,129,847 â–²	264.8%	275,944	5.2%	SPONSORED ADS
LQDA Liquidia	$26,874,654	$26,048,865 â–²	3,154.4%	712,100	4.6%	Medical
RVMD Revolution Medicines	$20,069,677	$16,469,482 â–²	457.5%	206,372	3.4%	Medical
APOGEE THERAPEUTICS INC	$18,727,825	$959,538 â–²	5.4%	222,500	3.2%	COM
BRIDGEBIO PHARMA INC	$18,565,000	$18,565,000 â–²	New Holding	250,000	3.2%	NOTE 1.750% 3/0
INCY Incyte	$17,264,337	$7,852,337 â–²	83.4%	183,429	2.9%	Medical
KOD Kodiak Sciences	$16,775,163	$15,646,811 â–²	1,386.7%	440,062	2.9%	Medical
CYTK Cytokinetics	$16,477,500	$16,477,500 â–²	New Holding	250,000	2.8%	Medical
JNJ Johnson & Johnson	$13,143,783	$15,319,788 â–¼	-53.8%	53,771	2.2%	Medical
COGT Cogent Biosciences	$12,423,186	$7,348,203 â–²	144.8%	322,764	2.1%	Medical
MRK Merck & Co., Inc.	$12,029,000	$12,029,000 â–²	New Holding	100,000	2.0%	Medical
JAZZ Jazz Pharmaceuticals	$10,351,433	$9,555,532 â–¼	-48.0%	54,755	1.8%	Medical
GPCR Structure Therapeutics	$9,627,179	$387,239 â–²	4.2%	199,734	1.6%	Medical
TERN Terns Pharmaceuticals	$9,581,965	$12,063,812 â–¼	-55.7%	181,752	1.6%	Medical
QURE uniQure	$9,486,270	$3,816,090 â–²	67.3%	580,200	1.6%	Medical
ROIV Roivant Sciences	$9,301,660	$473,670 â–²	5.4%	335,800	1.6%	Medical
BMRN BioMarin Pharmaceutical	$8,373,456	$105,523 â–²	1.3%	148,229	1.4%	Medical
MRNA Moderna	$8,097,520	$8,097,520 â–²	New Holding	159,400	1.4%	Medical
TGTX TG Therapeutics	$6,874,148	$543,313 â–¼	-7.3%	206,928	1.2%	Medical
CORT Corcept Therapeutics	$6,792,235	$2,569,561 â–¼	-27.4%	168,500	1.2%	Medical
EWTX Edgewise Therapeutics	$6,693,750	$5,748,750 â–²	608.3%	212,500	1.1%	Medical
BBIO BridgeBio Pharma	$6,335,195	$24,081,702 â–¼	-79.2%	85,311	1.1%	Medical
REPL Replimune Group	$5,860,359	$4,093,232 â–²	231.6%	766,060	1.0%	Medical
IMCR Immunocore	$5,824,648	$3,705,103 â–²	174.8%	193,189	1.0%	Medical
LLY Eli Lilly and Company	$5,518,620	$3,679,080 â–²	200.0%	6,000	0.9%	Medical
ABBV AbbVie	$5,232,374	$5,232,374 â–²	New Holding	24,058	0.9%	Medical
CRBP Corbus Pharmaceuticals	$5,213,863	$5,213,863 â–²	New Holding	555,257	0.9%	Medical
RCUS Arcus Biosciences	$5,143,867	$5,143,867 â–²	New Holding	238,142	0.9%	Medical
CRVS Corvus Pharmaceuticals	$5,136,754	$4,359,901 â–²	561.2%	351,111	0.9%	Medical
CRSP CRISPR Therapeutics	$5,056,691	$304,448 â–¼	-5.7%	106,300	0.9%	Medical
PCVX Vaxcyte	$4,542,517	$3,207,614 â–²	240.3%	78,171	0.8%	Medical
EYPT Eyepoint Pharmaceuticals	$3,671,652	$3,671,652 â–²	New Holding	284,845	0.6%	Medical
ZYMEWORKS INC	$3,558,985	$3,001,494 â–¼	-45.8%	142,132	0.6%	COM
GLUE Monte Rosa Therapeutics	$3,081,200	$2,056,678 â–²	200.7%	187,307	0.5%	Medical
ALUMIS INC	$2,890,336	$2,890,336 â–²	New Holding	131,200	0.5%	COM
TENAX THERAPEUTICS INC	$2,874,011	$1,014,278 â–¼	-26.1%	179,738	0.5%	COM NEW
ANNX Annexon	$2,693,083	$958,331 â–¼	-26.2%	486,116	0.5%	Medical
BHVN Biohaven	$2,681,820	$989,820 â–²	58.5%	317,000	0.5%	Medical
CELC Celcuity	$2,626,818	$2,626,818 â–²	New Holding	23,014	0.4%	Medical
HRMY Harmony Biosciences	$2,601,121	$2,391,046 â–²	1,138.2%	92,864	0.4%	Medical
NVO Novo Nordisk A/S	$2,575,061	$634,914 â–²	32.7%	70,477	0.4%	Medical
NTLA Intellia Therapeutics	$2,564,000	$4,221,626 â–¼	-62.2%	200,000	0.4%	Medical
VYGR Voyager Therapeutics	$2,214,258	$2,214,258 â–²	New Holding	573,642	0.4%	Medical
BCYC Bicycle Therapeutics	$2,210,607	$2,210,607 â–²	New Holding	476,424	0.4%	Medical
INDIVIOR PHARMACEUTICALS INC	$2,175,540	$2,175,540 â–²	New Holding	71,376	0.4%	COM
ELYM Eliem Therapeutics	$1,959,963	$1,959,963 â–²	New Holding	286,126	0.3%	Medical
IVA Inventiva	$1,935,023	$99,651 â–²	5.4%	352,399	0.3%	Medical
STTK Shattuck Labs	$1,888,260	$1,888,260 â–²	New Holding	293,664	0.3%	Medical
TARS Tarsus Pharmaceuticals	$1,819,831	$1,819,831 â–²	New Holding	25,942	0.3%	Medical
ALKS Alkermes	$1,768,000	$1,768,000 â–²	New Holding	50,000	0.3%	Medical
MGNX MacroGenics	$1,734,000	$1,734,000 â–²	New Holding	600,000	0.3%	Medical
CTMX CytomX Therapeutics	$1,485,200	$1,485,200 â–²	New Holding	316,000	0.3%	Medical
AVXL Anavex Life Sciences	$1,466,232	$1,034,590 â–²	239.7%	477,600	0.2%	Medical
RLMD Relmada Therapeutics	$1,397,860	$1,312,329 â–¼	-48.4%	200,842	0.2%	Medical
KARYOPHARM THERAPEUTICS INC	$1,344,041	$1,344,041 â–²	New Holding	241,300	0.2%	COM NEW
SLS SELLAS Life Sciences Group	$1,269,000	$528,327 â–¼	-29.4%	300,000	0.2%	Medical
OLMA Olema Pharmaceuticals	$1,252,440	$180,411 â–¼	-12.6%	84,000	0.2%	Medical
CRMD CorMedix	$1,137,325	$57,715 â–²	5.3%	167,500	0.2%	Medical
INOVIO PHARMACEUTICALS INC	$1,109,885	$7,278 â–²	0.7%	637,865	0.2%	COM SHS
IOVA Iovance Biotherapeutics	$1,063,179	$1,063,179 â–²	New Holding	302,900	0.2%	Medical
BIOAGE LABS INC	$1,049,400	$4,088,532 â–¼	-79.6%	60,000	0.2%	COM
AYTU Aytu BioPharma	$963,900	$129,099 â–²	15.5%	353,077	0.2%	Medical
OCGN Ocugen	$905,000	$905,000 â–²	New Holding	500,000	0.2%	Medical
EQ Equillium	$867,688	$172,902 â–²	24.9%	433,844	0.1%	Medical
DIANTHUS THERAPEUTICS INC	$839,200	$839,200 â–²	New Holding	10,000	0.1%	COM
PHVS Pharvaris	$828,318	$828,318 â–²	New Holding	29,321	0.1%	Medical
ENTA Enanta Pharmaceuticals	$820,344	$2,349 â–¼	-0.3%	64,952	0.1%	Medical
IBRX ImmunityBio	$815,321	$815,321 â–²	New Holding	106,300	0.1%	Medical
VIR Vir Biotechnology	$795,648	$899,584 â–¼	-53.1%	88,800	0.1%	Medical
XERS Xeris Biopharma	$769,927	$219,368 â–¼	-22.2%	132,746	0.1%	Medical
LRMR Larimar Therapeutics	$749,867	$749,867 â–²	New Holding	166,637	0.1%	Medical
RARE Ultragenyx Pharmaceutical	$736,267	$1,358,734 â–¼	-64.9%	35,144	0.1%	Medical
MLYS Mineralys Therapeutics	$713,740	$36,490 â–²	5.4%	26,347	0.1%	Medical
UNICYCIVE THERAPEUTICS INC	$698,026	$698,026 â–²	New Holding	106,083	0.1%	COM NEW
SPRUCE BIOSCIENCES INC	$653,500	$653,500 â–²	New Holding	10,000	0.1%	COM NEW
PHAT Phathom Pharmaceuticals	$607,162	$607,162 â–²	New Holding	54,650	0.1%	Medical
CONNECT BIOPHARMA HLDGS LTD	$525,808	$525,808 â–²	New Holding	200,690	0.1%	SHS
PELTHOS THERAPEUTICS INC	$520,481	$4,769 â–¼	-0.9%	24,773	0.1%	COM SHS
EOLS Evolus	$514,572	$26,304 â–²	5.4%	125,200	0.1%	Medical
MNKD MannKind	$457,177	$1,635,856 â–¼	-78.2%	186,603	0.1%	Medical
MAZE THERAPEUTICS INC	$447,750	$447,750 â–²	New Holding	15,000	0.1%	COM
JANX Janux Therapeutics	$439,240	$22,240 â–²	5.3%	31,600	0.1%	Medical
URGN Urogen Pharma	$416,327	$24,183 â–²	6.2%	23,155	0.1%	Medical
LPCN Lipocine	$399,500	$1,685,403 â–¼	-80.8%	50,000	0.1%	Medical
FHTX Foghorn Therapeutics	$382,132	$235,721 â–²	161.0%	79,944	0.1%	Medical
GHRS GH Research	$377,314	$377,314 â–²	New Holding	26,836	0.1%	Medical
PRQR ProQR Therapeutics	$291,734	$20,333 â–²	7.5%	180,083	0.0%	Medical
EUPRAXIA PHARMACEUTICALS INC	$289,600	$289,600 â–²	New Holding	40,000	0.0%	COM
PEPG PepGen	$267,137	$267,137 â–²	New Holding	150,925	0.0%	Medical
TRVI Trevi Therapeutics	$258,440	$900,967 â–¼	-77.7%	21,663	0.0%	Medical
PGEN Precigen	$213,984	$213,984 â–²	New Holding	55,293	0.0%	Medical
UPSTREAM BIO INC	$194,481	$9,981 â–²	5.4%	21,609	0.0%	COM
CMPS Compass Pathways	$176,324	$176,324 â–²	New Holding	31,885	0.0%	Medical
PASSAGE BIO INC	$153,311	$153,311 â–²	New Holding	19,530	0.0%	COM NEW
TALPHERA INC	$114,696	$12,428 â–²	12.2%	153,563	0.0%	COM NEW
RCKT Rocket Pharmaceuticals	$109,473	$109,473 â–²	New Holding	30,579	0.0%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Diadema Partners Lp Top Holdings and 13F Report (2026)

About Diadema Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Diadema Partners Lp Top Holdings and 13F Report (2026)

About Diadema Partners Lp

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofDiadema Partners Lp

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools